THURSDAY, Aug. 27, 2020 — Young adults who’ve had attention-deficit/hyperactivity disorder (ADHD) since childhood are at increased risk for road crashes, researchers say. But there is no increased risk for those whose ADHD symptoms have decreased, according to the study published online recently in the Journal of the American Academy of Child and Adolescent Psychiatry.… Read More: ADHD May Help Predict Adults’ Car Crash Risk »
Inhaled NO increases oxygenation by dilating or opening constricted blood vessels, especially in more well-ventilated areas of the lung, thereby improving intrapulmonary shunt fraction, or the percentage of blood put out by the heart that is not completely oxygenated. A recent report from the Centers for Disease Control and Prevention (CDC) suggests that pregnant women… Read More: Mass. General tests new therapy for pregnant coronavirus patients »
FDA Approves Cystadrops (cysteamine) Ophthalmic Solution for the Ocular Manifestations of Cystinosis Print this page LEBANON, N.J., Aug. 25, 2020 /PRNewswire/ — Recordati Rare Diseases Inc., today announced the U.S. Food and Drug Administration (FDA) has approved Cystadrops (cysteamine ophthalmic solution) 0.37%. Cystadrops is a new, viscous eye drop solution that depletes corneal cystine crystal… Read More: FDA Approves Cystadrops (cysteamine) Ophthalmic Solution for the Ocular Manifestations… »
With hospital budgets decimated from COVID-related surgery cancellations, CIOs are looking for every possible way to cut costs. One obvious step is to stop paying for applications that are no longer part of an organization’s go-forward strategy. In this timely webinar, our panel of experts will help you: Understand the costs of running a legacy… Read More: Finding Cost Savings with Legacy Data Management »